To evaluate if TNFα blockade attenuates podocyte toxicity of FSGS sera, we assayed sera that showed significant toxicity (N = 48, Fig 1C) in the presence or absence of anti-TNFα receptor I and II blocking antibodies ([23]; Fig 3). This evidence concerns the gene TNF and focal segmental glomerulosclerosis.